[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

2019 Pulmonary Tuberculosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Pulmonary Tuberculosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Tuberculosis. It presents in-depth analysis of Pulmonary Tuberculosis clinical trials across markets and companies ...

April 2019 157 pages

2019 Pyelonephritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Pyelonephritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pyelonephritis. It presents in-depth analysis of Pyelonephritis clinical trials across markets and companies ...

April 2019 79 pages

2019 Rabies Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rabies Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rabies. It presents in-depth analysis of Rabies clinical trials across markets and companies ...

April 2019 95 pages

2019 Radiation Induced Nausea and Vomiting (RINV) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Radiation Induced Nausea and Vomiting (RINV) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Radiation Induced Nausea and Vomiting ...

April 2019 41 pages

2019 Radiculopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Radiculopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Radiculopathy. It presents in-depth analysis of Radiculopathy clinical trials across markets and companies ...

April 2019 111 pages

2019 Radiodermatitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Radiodermatitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Radiodermatitis. It presents in-depth analysis of Radiodermatitis clinical trials across markets and companies ...

April 2019 69 pages

2019 Ragweed Pollen Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Ragweed Pollen Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ragweed Pollen Allergy. It presents in-depth analysis of Ragweed Pollen Allergy clinical trials ...

April 2019 37 pages

2019 Raynauds Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Raynauds Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Raynauds Disease. It presents in-depth analysis of Raynauds Disease clinical trials across markets and companies ...

April 2019 64 pages

2019 Recurrent Abortion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Recurrent Abortion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Abortion. It presents in-depth analysis of Recurrent Abortion clinical trials across markets and companies ...

April 2019 70 pages

2019 Recurrent Glioblastoma Multiforme (GBM) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Recurrent Glioblastoma Multiforme (GBM) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Glioblastoma Multiforme (GBM). It presents in-depth analysis of Recurrent Glioblastoma Multiforme (GBM) clinical trials ...

April 2019 327 pages

2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Head And Neck ...

April 2019 220 pages

2019 Recurrent Malignant Glioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Recurrent Malignant Glioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Malignant Glioma. It presents in-depth analysis of Recurrent Malignant Glioma clinical trials ...

April 2019 170 pages

2019 Recurrent Medulloblastoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Recurrent Medulloblastoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Medulloblastoma. It presents in-depth analysis of Recurrent Medulloblastoma clinical trials across markets and companies ...

April 2019 67 pages

2019 Refractory Acute Myeloid Leukemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Refractory Acute Myeloid Leukemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Acute Myeloid Leukemia. It presents in-depth analysis of Refractory Acute Myeloid Leukemia clinical trials ...

April 2019 414 pages

2019 Refractory Anemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Refractory Anemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Anemia. It presents in-depth analysis of Refractory Anemia clinical trials across markets and companies ...

April 2019 70 pages

2019 Refractory Anemia With Excess Blasts Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Refractory Anemia With Excess Blasts Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Anemia With Excess Blasts. It presents in-depth analysis of Refractory Anemia With Excess Blasts ...

April 2019 62 pages

2019 Refractory Anemia With Ringed Sideroblasts Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Refractory Anemia With Ringed Sideroblasts Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Anemia With Ringed Sideroblasts. It presents in-depth analysis of Refractory Anemia With Ringed Sideroblasts ...

April 2019 39 pages

2019 Refractory Angina Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Refractory Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Angina. It presents in-depth analysis of Refractory Angina clinical trials across markets and companies ...

April 2019 38 pages

2019 Refractory Chronic Lymphocytic Leukemia (CLL) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Refractory Chronic Lymphocytic Leukemia (CLL) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Chronic Lymphocytic Leukemia (CLL). It presents in-depth analysis of Refractory Chronic Lymphocytic Leukemia (CLL ...

April 2019 280 pages

2019 Regurgitation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Regurgitation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Regurgitation. It presents in-depth analysis of Regurgitation clinical trials across markets and companies ...

April 2019 65 pages

2019 Relapsed Acute Myeloid Leukemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Relapsed Acute Myeloid Leukemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Relapsed Acute Myeloid Leukemia. It presents in-depth analysis of Relapsed Acute Myeloid Leukemia clinical trials ...

April 2019 417 pages

2019 Relapsed Chronic Lymphocytic Leukemia (CLL) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Relapsed Chronic Lymphocytic Leukemia (CLL) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Relapsed Chronic Lymphocytic Leukemia (CLL). It presents in-depth analysis of Relapsed Chronic Lymphocytic Leukemia (CLL ...

April 2019 282 pages

2019 Relapsing Multiple Sclerosis (RMS) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Relapsing Multiple Sclerosis (RMS) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Relapsing Multiple Sclerosis (RMS). It presents in-depth analysis of Relapsing Multiple Sclerosis (RMS) clinical trials ...

April 2019 408 pages

2019 Renal Anemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Renal Anemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Renal Anemia. It presents in-depth analysis of Renal Anemia clinical trials across markets and companies ...

April 2019 236 pages

2019 Renal Artery Stenosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Renal Artery Stenosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Renal Artery Stenosis. It presents in-depth analysis of Renal Artery Stenosis clinical trials ...

April 2019 49 pages

2019 Renal Colic Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Renal Colic Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Renal Colic. It presents in-depth analysis of Renal Colic clinical trials across markets and companies ...

April 2019 64 pages

2019 Renal Pain (Kidney Pain) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Renal Pain (Kidney Pain) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Renal Pain (Kidney Pain). It presents in-depth analysis of Renal Pain (Kidney Pain) clinical trials ...

April 2019 125 pages

2019 Renal Stones/Calculi Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Renal Stones/Calculi Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Renal Stones/Calculi. It presents in-depth analysis of Renal Stones/Calculi clinical trials across markets and companies ...

April 2019 125 pages

2019 Reperfusion Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Reperfusion Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Reperfusion Injury. It presents in-depth analysis of Reperfusion Injury clinical trials across markets and companies ...

April 2019 150 pages

2019 Resistant Hypertension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Resistant Hypertension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Resistant Hypertension. It presents in-depth analysis of Resistant Hypertension clinical trials across markets and companies ...

April 2019 125 pages

2019 Respiratory Depression (Hypoventilation) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Respiratory Depression (Hypoventilation) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Respiratory Depression (Hypoventilation). It presents in-depth analysis of Respiratory Depression (Hypoventilation) clinical trials ...

April 2019 65 pages

2019 Respiratory Distress Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Respiratory Distress Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Respiratory Distress Syndrome. It presents in-depth analysis of Respiratory Distress Syndrome clinical trials ...

April 2019 248 pages

2019 Respiratory Failure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Respiratory Failure Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Respiratory Failure. It presents in-depth analysis of Respiratory Failure clinical trials across markets and companies ...

April 2019 229 pages

2019 Respiratory Syncytial Virus (RSV) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Respiratory Syncytial Virus (RSV) Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Respiratory Syncytial Virus (RSV) Infections. It presents in-depth analysis of Respiratory Syncytial Virus (RSV) Infections ...

April 2019 153 pages

2019 Restenosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Restenosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Restenosis. It presents in-depth analysis of Restenosis clinical trials across markets and companies ...

April 2019 187 pages

2019 Restless Legs Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Restless Legs Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Restless Legs Syndrome. It presents in-depth analysis of Restless Legs Syndrome clinical trials ...

April 2019 98 pages

2019 Retinal Degeneration Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Retinal Degeneration Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinal Degeneration. It presents in-depth analysis of Retinal Degeneration clinical trials across markets and companies ...

April 2019 92 pages

2019 Retinal Pigment Epithelial Detachment Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Retinal Pigment Epithelial Detachment Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinal Pigment Epithelial Detachment. It presents in-depth analysis of Retinal Pigment Epithelial Detachment clinical trials ...

April 2019 45 pages

2019 Retinal Vein Occlusion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Retinal Vein Occlusion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinal Vein Occlusion. It presents in-depth analysis of Retinal Vein Occlusion clinical trials ...

April 2019 172 pages

2019 Retinitis Pigmentosa (Retinitis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Retinitis Pigmentosa (Retinitis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinitis Pigmentosa (Retinitis). It presents in-depth analysis of Retinitis Pigmentosa (Retinitis) clinical trials ...

April 2019 66 pages

2019 Retinoblastoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Retinoblastoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinoblastoma. It presents in-depth analysis of Retinoblastoma clinical trials across markets and companies ...

April 2019 66 pages

2019 Retinopathy Of Prematurity Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Retinopathy Of Prematurity Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinopathy Of Prematurity. It presents in-depth analysis of Retinopathy Of Prematurity clinical trials ...

April 2019 77 pages

2019 Rhabdomyosarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rhabdomyosarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rhabdomyosarcoma. It presents in-depth analysis of Rhabdomyosarcoma clinical trials across markets and companies ...

April 2019 124 pages

2019 Rheumatic Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rheumatic Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rheumatic Disorders. It presents in-depth analysis of Rheumatic Disorders clinical trials across markets and companies ...

April 2019 150 pages

2019 Rhinitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rhinitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rhinitis. It presents in-depth analysis of Rhinitis clinical trials across markets and companies ...

April 2019 417 pages

2019 Rhino-Conjunctivitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rhino-Conjunctivitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rhino-Conjunctivitis. It presents in-depth analysis of Rhino-Conjunctivitis clinical trials across markets and companies ...

April 2019 102 pages

2019 Rhinovirus Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rhinovirus Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rhinovirus Infections. It presents in-depth analysis of Rhinovirus Infections clinical trials across markets and companies ...

April 2019 53 pages

2019 Rosacea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rosacea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rosacea. It presents in-depth analysis of Rosacea clinical trials across markets and companies ...

April 2019 141 pages

2019 Rotavirus Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Rotavirus Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rotavirus Infections. It presents in-depth analysis of Rotavirus Infections clinical trials across markets and companies ...

April 2019 59 pages

2019 Round Cell Liposarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Round Cell Liposarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Round Cell Liposarcoma. It presents in-depth analysis of Round Cell Liposarcoma clinical trials ...

April 2019 48 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers